In recent years, the competition for generic drugs has become increasingly fierce. Improved new drugs have been favored by pharmaceutical companies and have begun large-scale deployment. They have gradually ushered in the harvest period. 2023 will be a fruitful year for improved new drugs. According to statistics from Yaorongyun, Class 2 improved new drugs will achieve an overall growth of 38% in 2023. However, since it is an improvement, it must achieve transcendence in imitation, and it must have higher and stronger technical support. Problems and difficulties often encounter challengers unexpectedly during the research and development process. During this period, some people There are confusions and failures, and some people have successes and experiences.

In order to help companies break through technical barriers and promote in-depth exchanges and cooperation among all parties, the Pharmaceutical Finance Circle will hold a private meeting on practical cases of improved new drugs on August 15-16, 2024, inviting experts from scientific research institutes and entrepreneurs who are deeply involved in the industry to gather. Suzhou has gathered to become the most powerful pharmaceutical group, sharing cases around 9 special sessions of oral dissolving film, transdermal, microsphere, nano, liposome, solid, inhalation, ophthalmology, and children. Friends from all walks of life are welcome to come to the event for exchanges and discussions.